Jacqueline Vuky
Hematology & Oncology · Portland, ORNPI 1851462998
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Seagen Inc. at 56.2% of the total. Reporting peaked in 2019 at $5,095 and has fallen 98.1% since, to $98 in 2025.
Across 19 payments — averaging $473.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$5K
- AstraZeneca$2K
- E.r. Squibb & Sons, L.L.C.$1K
- Exelixis Inc.$67
- Merck$61
- Daiichi Sankyo Inc.$61
- plus $50 from 2 others
Across 712 payments — averaging $7647.77 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$1.5M
- Exelixis Inc.$1M
- Eli Lilly$939K
- Astrazeneca UK Limited$428K
- E.r. Squibb & Sons, L.L.C.$253K
- Eisai Inc.$243K
- plus $1.1M from 13 others
What the payments were for
- Consulting fees$3,62840%
- Speaking & faculty fees$4,65052%
- Travel & lodging$2483%
- Food & beverage$4345%
- Education$350%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 7 | $5,055 |
| AstraZeneca | 4 | $2,460 |
| E.r. Squibb & Sons, L.L.C. | 2 | $1,242 |
| Exelixis Inc. | 1 | $67 |
| Merck | 2 | $61 |
| Daiichi Sankyo Inc. | 1 | $61 |
| Genentech, Inc. | 1 | $38 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,994 in reported general payments places this provider in the 80th percentile of 112 hematology & oncology providers in Oregon.
Other hematology & oncology in Portland
- Brian DrukerPortland$1.9M
- Jay AndersenPortland$196K
- Richard MaziarzPortland$174K
- Tibor KovacsovicsPortland$119K
- Elie TraerPortland$72K
- Jeffrey MenashePortland$38K
- Michael HeinrichPortland$37K
- Lucy LangerPortland$18K
- Miklos SimonPortland$13K
- Alexandra SokolovaPortland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.